Clinical Trials Browser

Phase 1 × Advanced Malignancies × MLN 8237 × Clear all

NCT00651664 2019-03-15

A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies

Phase 1 Completed

59 enrolled 51 charts

Advanced Malignancies

NCT00500903 2019-03-14

A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors

Phase 1 Completed

87 enrolled 68 charts

Advanced Malignancies